BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 19021311)

  • 1. Molecular imaging with optics: primer and case for near-infrared fluorescence techniques in personalized medicine.
    Sevick-Muraca EM; Rasmussen JC
    J Biomed Opt; 2008; 13(4):041303. PubMed ID: 19021311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual optical and nuclear imaging in human melanoma xenografts using a single targeted imaging probe.
    Li C; Wang W; Wu Q; Ke S; Houston J; Sevick-Muraca E; Dong L; Chow D; Charnsangavej C; Gelovani JG
    Nucl Med Biol; 2006 Apr; 33(3):349-58. PubMed ID: 16631083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality analysis of in vivo near-infrared fluorescence and conventional gamma images acquired using a dual-labeled tumor-targeting probe.
    Houston JP; Ke S; Wang W; Li C; Sevick-Muraca EM
    J Biomed Opt; 2005; 10(5):054010. PubMed ID: 16292970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody vectors for imaging.
    Olafsen T; Wu AM
    Semin Nucl Med; 2010 May; 40(3):167-81. PubMed ID: 20350626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smart optical probes for near-infrared fluorescence imaging of Alzheimer's disease pathology.
    Raymond SB; Skoch J; Hills ID; Nesterov EE; Swager TM; Bacskai BJ
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35 Suppl 1():S93-8. PubMed ID: 18236039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticles for optical molecular imaging of atherosclerosis.
    Douma K; Prinzen L; Slaaf DW; Reutelingsperger CP; Biessen EA; Hackeng TM; Post MJ; van Zandvoort MA
    Small; 2009 Mar; 5(5):544-57. PubMed ID: 19226595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggregation-Induced Emission Luminogen with Near-Infrared-II Excitation and Near-Infrared-I Emission for Ultradeep Intravital Two-Photon Microscopy.
    Qi J; Sun C; Li D; Zhang H; Yu W; Zebibula A; Lam JWY; Xi W; Zhu L; Cai F; Wei P; Zhu C; Kwok RTK; Streich LL; Prevedel R; Qian J; Tang BZ
    ACS Nano; 2018 Aug; 12(8):7936-7945. PubMed ID: 30059201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular imaging in gastrointestinal disease.
    Mahmood U; Wallace MB
    Gastroenterology; 2007 Jan; 132(1):11-4. PubMed ID: 17241854
    [No Abstract]   [Full Text] [Related]  

  • 9. Nuclear and optical dual-labelled imaging agents. Design and challenges.
    Singh G; Gott MD; Pietzsch HJ; Stephan H
    Nuklearmedizin; 2016; 55(2):41-50. PubMed ID: 27067792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Near-field optics: from subwavelength illumination to nanometric shadowing.
    Lewis A; Taha H; Strinkovski A; Manevitch A; Khatchatouriants A; Dekhter R; Ammann E
    Nat Biotechnol; 2003 Nov; 21(11):1378-86. PubMed ID: 14595366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodality molecular imaging with combined optical and SPECT/PET modalities.
    Culver J; Akers W; Achilefu S
    J Nucl Med; 2008 Feb; 49(2):169-72. PubMed ID: 18199608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary optical and nuclear imaging of caspase-3 activity using combined activatable and radio-labeled multimodality molecular probe.
    Lee H; Akers WJ; Cheney PP; Edwards WB; Liang K; Culver JP; Achilefu S
    J Biomed Opt; 2009; 14(4):040507. PubMed ID: 19725712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can nuclear medicine shed light on the dark side of angiogenesis in cardiovascular disease?
    Slart RH; Zeebregts CJ; Tio RA
    Nucl Med Commun; 2008 Jul; 29(7):585-7. PubMed ID: 18528178
    [No Abstract]   [Full Text] [Related]  

  • 14. How much CT is needed in nuclear medicine.
    Shah C; Patton JA; Sandler MP
    Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1759-60. PubMed ID: 18542958
    [No Abstract]   [Full Text] [Related]  

  • 15. SNM molecular imaging summit introduces clinical trials network.
    McEwan AS; Graham MM; Conti PS
    J Nucl Med; 2009 Apr; 50(4):18N. PubMed ID: 19339670
    [No Abstract]   [Full Text] [Related]  

  • 16. New agents and techniques for imaging prostate cancer.
    Zaheer A; Cho SY; Pomper MG
    J Nucl Med; 2009 Sep; 50(9):1387-90. PubMed ID: 19690043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Optical imaging of fluorescence in the near infrared. From passive to enzymatically activated contrast medium].
    Funovics M
    Radiologe; 2007 Jan; 47(1):53-61. PubMed ID: 17216511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current advances in molecular imaging of gene and cell therapy for cancer.
    Shah K
    Cancer Biol Ther; 2005 May; 4(5):518-23. PubMed ID: 15908803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creating a new, smarter health care.
    Wagner HN
    J Nucl Med; 2009 Sep; 50(9):14N-32N. PubMed ID: 19713557
    [No Abstract]   [Full Text] [Related]  

  • 20. Development and in vivo imaging of a PET/MRI nanoprobe with enhanced NIR fluorescence by dye encapsulation.
    Kim JS; Kim YH; Kim JH; Kang KW; Tae EL; Youn H; Kim D; Kim SK; Kwon JT; Cho MH; Lee YS; Jeong JM; Chung JK; Lee DS
    Nanomedicine (Lond); 2012 Feb; 7(2):219-29. PubMed ID: 22175235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.